- 09:00 Clonal hematopoiesis and evolution to MPN/AML (Ross L. Levine, New York)
- 09:30 Molecular regulators of dormant hematopoietic stem cells (Nina Cabezas-Wallscheid, Freiburg)
- 10:00 Long-term outcomes of therapy in AML (Lars Bullinger, Berlin)
- 10:30 Ribosomal RNA mediated cellular plasticity in AML (Carsten Mùˆller-Tidow, Heidelberg)
- 11:00 COFFEE BREAK
